Kicort 24 Tablet contains Deflazacort 24mg, a synthetic corticosteroid with potent anti-inflammatory and immunosuppressive properties. It is primarily indicated for the management of various inflammatory and autoimmune conditions, including rheumatoid arthritis, systemic lupus erythematosus, polymyositis, and certain allergic reactions. Deflazacort exerts its therapeutic effects by modulating the immune response and reducing the production of inflammatory mediators, thereby alleviating symptoms such as swelling, pain, and tissue damage. Kicort 24 is also utilized in the treatment of chronic respiratory diseases, dermatological disorders, and as an adjunct therapy in certain hematological and oncological conditions. The drug is administered orally and should be used under strict medical supervision, with dosage tailored according to the severity of the condition and patient response. Caution is advised in patients with infections, diabetes, hypertension, osteoporosis, or gastrointestinal ulcers, as corticosteroids may exacerbate these conditions. Long-term use requires monitoring for potential side effects such as adrenal suppression, hyperglycemia, and increased susceptibility to infections. Abrupt discontinuation is discouraged to prevent withdrawal symptoms. Overall, Kicort 24 Tablet offers an effective therapeutic option for controlling inflammation and immune-mediated diseases when used appropriately.